Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ultragenyx Pharmaceutical

39.30
+0.33000.85%
Post-market: 39.300.00000.00%16:07 EDT
Volume:1.04M
Turnover:41.32M
Market Cap:3.69B
PE:-6.25
High:40.13
Open:39.20
Low:39.18
Close:38.97
Loading ...

Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update

GlobeNewswire
·
07 Feb

Ultragenyx Pharmaceutical Presents New Data for UX111 Gene Therapy, Expects FDA Approval Decision in H2

MT Newswires Live
·
05 Feb

Ultragenyx announces new data on UX111 AV gene therapy

TIPRANKS
·
05 Feb

Ultragenyx Pharmaceutical Inc - Pdufa Decision and Potential U.S. Launch Expected in H2 2025

THOMSON REUTERS
·
05 Feb

Ultragenyx Pharmaceutical Inc - Mitt Group Shows +22.7 Point Treatment Effect in Bayley-Iii Cognitive Score

THOMSON REUTERS
·
05 Feb

Ultragenyx Announces New Data Demonstrating that Treatment with UX111 AAV Gene Therapy Significantly Improved Clinical Function Across Multiple Developmental Domains in Children with Sanfilippo Syndrome Type A (MPS IIIA) Correlated with Sustained Reductions in CSF-HS

GlobeNewswire
·
05 Feb

Wedbush Trims Price Target on Ultragenyx Pharmaceutical to $47 From $48, Keeps Neutral Rating

MT Newswires Live
·
23 Jan

Ultragenyx Pharma Price Target Maintained With a $118.00/Share by Cantor Fitzgerald

Dow Jones
·
23 Jan

Rhythm Pharmaceuticals (RYTM) Soars 5.5%: Is Further Upside Left in the Stock?

Zacks
·
22 Jan

U.S. RESEARCH ROUNDUP- Apple, Murphy USA, UnitedHealth

Reuters
·
21 Jan

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
18 Jan

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
18 Jan

Why Ultragenyx Pharmaceutical (RARE) Is the Biotech Stock with the Biggest Upside Potential

Insider Monkey
·
18 Jan

Ultragenyx's Multiple Commercial Assets And Candidates Impress Analyst; Sees Solid Upside

Benzinga
·
16 Jan

Ultragenyx Pharma Price Target Maintained With a $48.00/Share by Wedbush

Dow Jones
·
13 Jan

Ultragenyx Pharmaceutical (RARE) Receives a Hold from Wedbush

TIPRANKS
·
13 Jan

Evercore ISI Sticks to Their Buy Rating for Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
13 Jan

U.S. RESEARCH ROUNDUP- Constellation Brands, Merck, WD-40

Reuters
·
13 Jan

Ultragenyx Pharmaceutical Inc : Piper Sandler Raises Target Price to $140 From $135

THOMSON REUTERS
·
13 Jan

Strong Buy Recommendation for Ultragenyx Pharmaceutical Based on Robust Performance and Promising Clinical Pipeline

TIPRANKS
·
13 Jan